Research Paper Volume 13, Issue 21 pp 24017—24036
Low-protein diet applied as part of combination therapy or stand-alone normalizes lifespan and tumor proliferation in a model of intestinal cancer
- 1 Department of Molecular Physiology, Zoological Institute, Kiel University, Kiel, Germany
- 2 Airway Research Center North (ARCN), German Center for Lung Research (DZL), Kiel, Germany
Received: July 15, 2021 Accepted: October 26, 2021 Published: November 12, 2021
https://doi.org/10.18632/aging.203692How to Cite
Copyright: © 2021 Proske et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Tumors of the intestinal tract are among the most common tumor diseases in humans, but, like many other tumor entities, show an unsatisfactory prognosis with a need for effective therapies. To test whether nutritional interventions and a combination with a targeted therapy can effectively cure these cancers, we used the fruit fly Drosophila as a model. In this system, we induced tumors by EGFR overexpression in intestinal stem cells. Limiting the amount of protein in the diet restored life span to that of control animals. In combination with a specific EGFR inhibitor, all major tumor-associated phenotypes could be rescued. This form of treatment was also successful in a real treatment scenario, which means when they started after the full tumor phenotype was expressed. In conclusion, reduced protein administration can be a very promising form of adjuvant cancer therapy.